- Rocapine, a wellness venture studio based in Paris, has raised $13M in Series A funding. The round was led by Educapital, with support from Daphni, Ring Capital, Centre Court Capital, and Jean-Charles Samuelian-Werve, co-founder of Alan.
- By applying mobile gaming’s fast-launch strategies to wellness, one app reached $1M in annual recurring revenue just 16 days after launch.
- In 2025, global revenue from non-gaming apps topped mobile gaming for the first time, hitting $86B. Wellness apps are one of the fastest-growing areas.
On average, people will spend 15 years of their lives using smartphones. Rocapine believes the same techniques that made phones addictive can be used for good, and early results back this up.
Today, this Paris-based AI wellness venture studio raised $13M in Series A funding led by Educapital. Other investors include Daphni, Ring Capital, Centre Court Capital, Athletico Ventures, and Better Angle.
Angel investors include Jean-Charles Samuelian-Werve, co-founder and CEO of Alan, and the founders of Opal and Yubo. This round comes after a seed round led by Daphni in late 2024.
The studio was founded in 2024 by Stanislas Marchand, who previously worked at mobile gaming company Voodoo, together with Jean-Gabriel Boinot-Tramoni and Sammy Teillet.
How Rocapine applies gaming strategies to wellness
Rocapine takes inspiration from mobile gaming. Rather than building just one app, the studio tests hundreds of ideas each year, working with independent developers to quickly see what works.
If an idea shows promise, Rocapine turns it into a polished, personalised product and quickly scales it using AI and performance marketing. This year, the studio plans to test up to 400 apps.
This strategy has led to five successful consumer apps in under a year. These include Harmony, a cycle-tracking and women’s wellbeing app; That Girl, a daily habit-building tool; and Unchaind, which helps users overcome compulsive porn use. Unchaind hit $1M in annual recurring revenue just 16 days after launch.
“As soon as we started scaling with paid marketing, the signal was unmistakable. Strong retention in the first days, high conversion to paid, and an acquisition cost that the revenue could more than cover. When those lines up this early, you know you have something rare,” Marchand tells Tech Funding News.
Across all their apps, Rocapine reached $6M in annual recurring revenue within nine months of launch, with 2.5 million downloads and 70% of revenue coming from the US.
A crowded market and a structural approach
Calm has raised over $200M and was last valued at about $2B. Headspace merged with Ginger in 2021 in a $3B deal, and both lead the mindfulness space. Noom, which focuses on weight management, has also raised over $500M using a similar rapid-growth approach.
Rocapine stands out for focusing on structure rather than just the product. While others put all their efforts into a single app, Rocapine builds a portfolio, becoming more efficient and cost-effective with every test.
Marchand says that failure is built into their model. Out of about 400 concepts tested this year as simple prototypes, they expect around 100 to move forward, 20 to be fully developed, and only five to ten to become real successes.
“The vast majority fail, and that’s exactly how it should work. Each concept is tested with real users and paid acquisition within days. If the early signal isn’t there — weak retention, low conversion, acquisition costs the revenue can’t cover — we move on. No emotional attachment,” he notes.
This moment marks a big change in the market. Non-gaming app revenue beat mobile gaming worldwide for the first time in 2025, reaching $86B. Oxford even named “brain rot” the word of the year for 2024, and ADHD diagnoses in US children have doubled since the 1990s.
“The best consumer products earn trust by improving people’s lives. That’s exactly what Rocapine does, using AI to craft deeply personalised wellness apps and scale them faster than anyone in the space. They’ve built multiple hits in under a year while staying true to a mission that matters”, says Jean-Charles Samuelian-Werve, co-founder and CEO of Alan, and early investor in Rocapine.
What the money is for
Marchand took an unusual path to wellness apps. While at Voodoo, he saw firsthand how much time people spent on attention-grabbing games and the effects it had.
“One day, I figured out how much human time was spent on just one game we were scaling. It added up to thousands of years of life, spent on something that didn’t make anyone smarter or healthier. That scared me. It made me wonder: what if we used those same skills to help people instead? I decided to use those skills to make smartphones support wellbeing, not work against it,” he concludes.
Alexandre Glaser, investment director at Educapital, whose portfolio includes Preply, 360Learning, and Knowunity, says the firm was attracted by Rocapine’s speed of execution.
“In less than a year, the team has done what most studios take years to attempt: build multiple hits, crack distribution and generate real revenue at speed. What strikes us most is their rare combination of product instinct and execution velocity,” he adds.
Rocapine plans to use the new funding to boost its AI, data, and marketing systems, build on its early wins to become a leader in the field, and expand its ability to test new ideas. The company’s goal is to improve the lives of at least 40 million people in the next five years.
It’s still unclear if a fast-moving portfolio approach can build the deep user loyalty needed to stay on top, or if Rocapine will just keep chasing the next big thing. The next 18 months will show whether their early success is here to stay or just a short-term trend.
